Sponsors Request More Bioequivalence Details in Guidance

Sponsors would like to see clearer recommendations for non-inferiority assessments, demonstrating bioequivalence and targets for statistical analysis, before the European Medicines Agency adopts an international guideline on large clinical trials that span multiple regions.
Source: International Pharmaceutical Regulatory Monitor